Hydrocephalus has a genetic cause in a meaningful minority of cases, but most of the time it results from something other than an inherited mutation. A systematic review of exome sequencing studies found that roughly 38% of congenital hydrocephalus cases had an identifiable genetic diagnosis, though that number dropped to about 21% when only isolated, non-syndromic cases were counted. The rest arise from infections, bleeding in the brain, tumors, or structural malformations that developed during fetal life without a clear single-gene trigger. For families trying to understand recurrence risk or plan future pregnancies, the distinction between genetic and non-genetic hydrocephalus matters enormously, and drawing that line is not always straightforward.
What Hydrocephalus Actually Is
Hydrocephalus is a buildup of cerebrospinal fluid (CSF) inside the brain’s ventricles, the interconnected chambers where fluid normally circulates before being absorbed. When that fluid accumulates faster than it drains, the ventricles expand and press on surrounding brain tissue, which can cause developmental problems in infants or cognitive and motor symptoms in adults. Historically, doctors assumed CSF was mainly produced by the choroid plexus, a network of blood vessels inside the ventricles, and absorbed through structures called arachnoid granulations near the top of the brain. More recent work suggests the picture is more complicated: CSF is also generated from fluid within the brain tissue itself, and much of the absorption happens through lymphatic vessels in the membranes surrounding the brain rather than exclusively through the arachnoid granulations.1PubMed Central. Cerebrospinal Fluid Production and Absorption and Ventricular Enlargement Mechanisms in Hydrocephalus Any disruption along this production-and-drainage loop, whether caused by a genetic defect, an infection, or a physical blockage, can lead to hydrocephalus.
Single-Gene Causes That Run in Families
The clearest examples of inherited hydrocephalus involve mutations in a single gene that directly disrupts brain development or CSF flow. The best-known is X-linked hydrocephalus, caused by mutations in a gene called L1CAM. The L1 protein helps nerve cells stick together and migrate to the right locations during brain development. When L1CAM is mutated, the resulting condition can include hydrocephalus, problems with the band of nerve fibers connecting the brain’s two hemispheres, and spastic movements of the legs. Because L1CAM sits on the X chromosome, this form primarily affects boys, while mothers who carry the mutation typically show no symptoms themselves.2PubMed. Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): Mutations in the L1CAM gene
Other single-gene causes are rarer and tend to follow a recessive inheritance pattern, meaning a child needs to inherit a faulty copy from both parents. One example involves the gene CCDC88C, which plays a role in a cell-signaling pathway important for brain development. Families with two copies of certain CCDC88C mutations have been identified with severe hydrocephalus that begins before birth.3PubMed Central. Bi-allelic mutations of CCDC88C are a rare cause of severe congenital hydrocephalus
A separate group of genetic causes involves the tiny hair-like structures called cilia that line the inside of the brain’s ventricles. These cilia beat in coordinated waves to help push CSF through the ventricular system. Mutations in genes that control cilia movement, such as DNAH5, can cripple this propulsion system. In animal models, mice lacking functional DNAH5 develop severe hydrocephalus shortly after birth.4PubMed Central. Ependymal ciliary motion and their role in congenital hydrocephalus In humans, these same cilia genes are involved in primary ciliary dyskinesia, a condition better known for causing chronic lung infections and situs inversus (organs positioned in mirror image). Hydrocephalus occurs in some people with ciliary dyskinesia, though not all, which suggests other factors modify whether faulty cilia lead to fluid buildup in any given person.5PubMed. Riding the wave of ependymal cilia: genetic susceptibility to hydrocephalus in primary ciliary dyskinesia
Chromosomal Problems and Copy Number Variations
Beyond single-gene mutations, hydrocephalus can result from larger-scale genetic disruptions. Certain chromosomal abnormalities, such as trisomies or large deletions and duplications of DNA segments, are sometimes detected in fetuses with enlarged ventricles. These copy number variations (CNVs) are not inherited in the straightforward way that single-gene conditions are; they often arise as new events during the formation of the egg or sperm. Research has shown that pathogenic CNVs represent an important genetic contributor to fetal ventriculomegaly and may also be linked to neurodevelopmental problems after birth.6PubMed. Copy number variations and fetal ventriculomegaly Because these rearrangements can involve many genes at once, the hydrocephalus they produce is frequently accompanied by other structural or developmental abnormalities, which can be a clue during prenatal evaluation.
Structural Brain Malformations That Lead to Hydrocephalus
Some cases of congenital hydrocephalus stem from brain malformations that form during embryonic development. Dandy-Walker malformation, for instance, involves abnormal development of the cerebellum and the fourth ventricle, and it often leads to hydrocephalus because the pathways that normally allow CSF to exit the fourth ventricle are blocked or absent.7PubMed Central. Dandy-Walker Malformation With Hydrocephalus: Diagnosis and Its Treatment The genetics of Dandy-Walker malformation are complex, involving multiple potential genes and environmental influences rather than a single predictable inheritance pattern.
Spina bifida is another developmental condition frequently associated with hydrocephalus. Children born with spina bifida, particularly the more severe open form called meningomyelocele, often develop an Arnold-Chiari type II malformation, where part of the brainstem is displaced downward through the base of the skull. This displacement obstructs CSF flow and leads to hydrocephalus in a large proportion of affected children.8PubMed Central. Spina bifida and other neural tube defects Neural tube defects like spina bifida have a partially genetic basis, with multiple genes (including SHH, ZIC2, SIX3, and others) contributing to the risk, but environmental factors like folate deficiency during early pregnancy also play a large role.9PubMed Central. Molecular Biology of Pediatric Hydrocephalus and Hydrocephalus-related Diseases This makes the hydrocephalus associated with spina bifida a product of both genetic susceptibility and prenatal environment, which is a useful illustration of why the “genetic or not” question rarely has a clean binary answer.
Acquired Causes With No Genetic Component
A substantial share of hydrocephalus cases are acquired, meaning something happened after conception that disrupted CSF flow in a brain that was otherwise developing normally. These causes are not heritable and carry no increased risk for future pregnancies.
Bleeding inside the brain’s ventricles is one of the most common acquired triggers, especially in premature infants. Intraventricular hemorrhage can leave behind blood clots and inflammatory debris that block the narrow passages CSF needs to travel through. A systematic review found that among premature infants who experienced intraventricular hemorrhage, about 58% went on to develop post-hemorrhagic hydrocephalus.10PubMed Central. Post-Hemorrhagic Hydrocephalus and Outcomes Amongst Neonates With Intraventricular Hemorrhage: A Systematic Review and Pooled Analysis The good news is that some of those cases resolve on their own, and infants whose hydrocephalus resolved had substantially better outcomes than those whose did not.
Infections are another major acquired cause. Bacterial meningitis, viral encephalitis, and congenital infections can all inflame the lining of the ventricles and the surrounding membranes, producing a thick inflammatory residue that physically blocks CSF drainage.11PubMed Central. Cytomegalovirus ventriculoencephalitis presenting with hydrocephalus in a patient with advanced HIV infection Even relatively uncommon pathogens can trigger it: there are documented cases of neonatal Listeria meningitis leading to hydrocephalus severe enough to require surgical shunt placement.12PubMed. Post-infectious hydrocephalus complicating Listeria meningitis in a healthy newborn In low-resource settings where neonatal infections are more common and less quickly treated, post-infectious hydrocephalus accounts for a large portion of all pediatric cases.
Brain tumors can also cause hydrocephalus by growing in locations that obstruct CSF pathways. Tumors in the dorsal midbrain, for example, can compress the narrow aqueduct connecting the third and fourth ventricles, producing what is called aqueductal stenosis. These tumors are often low-grade gliomas and can present in childhood or later in life.13Journal of Neurosurgery. The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors
Normal Pressure Hydrocephalus in Older Adults
Hydrocephalus is not exclusively a childhood condition. Normal pressure hydrocephalus (NPH) typically appears in people over 60 and causes a triad of symptoms: difficulty walking, cognitive decline, and urinary incontinence. The “normal pressure” label refers to the fact that CSF pressure readings can appear normal on a single measurement, even though the ventricles are enlarged. NPH has long been considered a condition of aging with unclear origins, but genetic research is starting to suggest that some people carry inherited susceptibility.
The most studied genetic link involves a deletion within the SFMBT1 gene. In a Japanese study, about 26% of patients with confirmed, shunt-responsive NPH carried this deletion, compared to roughly 4% of healthy controls, an odds ratio of nearly 8.14PubMed Central. A Segmental Copy Number Loss of the SFMBT1 Gene Is a Genetic Risk for Shunt-Responsive, Idiopathic Normal Pressure Hydrocephalus (iNPH): A Case-Control Study The same variant was also found at elevated rates in Finnish and Norwegian NPH patients, though at lower frequencies than in the Japanese cohort, and it did not reliably predict whether a patient would improve after shunt surgery in the European groups.15PubMed Central. Genetic Risk Factors in Normal Pressure Hydrocephalus: What We Know and What Is Next The SFMBT1 protein is present in the choroid plexus and the lining of the ventricles, which gives biological plausibility to the idea that changes in this gene could affect CSF dynamics. Still, the variant is best understood as a risk factor rather than a direct cause; plenty of carriers never develop NPH.
How Genetic Testing Fits Into Diagnosis
When a baby is diagnosed with hydrocephalus, one of the first questions parents ask is “why did this happen?” Genetic testing, particularly exome sequencing that surveys the protein-coding parts of the genome, can sometimes provide an answer. A meta-analysis of nine studies involving over 500 infants with congenital hydrocephalus found that exome sequencing yielded a molecular diagnosis in about 38% of cases overall. For children whose hydrocephalus appeared alongside other developmental anomalies, the yield was higher. For isolated hydrocephalus with no other visible problems, the diagnostic rate was closer to 21%.16PubMed Central. Molecular Diagnostic Yield of Exome Sequencing in Patients With Congenital Hydrocephalus: A Systematic Review and Meta-Analysis
Consanguinity, where the parents are blood relatives, dramatically raised the diagnostic yield to about 76%, reflecting the increased likelihood that both parents carry the same rare recessive mutation.16PubMed Central. Molecular Diagnostic Yield of Exome Sequencing in Patients With Congenital Hydrocephalus: A Systematic Review and Meta-Analysis This does not mean that families without consanguinity should skip testing, but it does help set expectations about what the test is likely to find. A negative genetic test result does not rule out all genetic contribution; it may just mean the causative variant is in a region that current sequencing does not cover well, or that the condition results from a complex interplay of multiple genes.
Recurrence Risk for Future Pregnancies
For families who have had one child with hydrocephalus, the recurrence risk depends heavily on the underlying cause. If a clear single-gene mutation has been identified, the risk follows the expected inheritance pattern: 50% for X-linked conditions in male offspring, 25% for autosomal recessive conditions when both parents are carriers. But when no specific genetic cause is found, estimating recurrence is harder.
A large genetic counseling study analyzed over 1,600 families and found that after excluding obviously single-gene cases, the recurrence rate of craniospinal defects (which included both neural tube defects and hydrocephalus) was about 3.7%, roughly ten times higher than the general population risk. The recurrence rate for hydrocephalus specifically was about 3%. Recurrence risk increased with the severity of the original anomaly and the number of affected relatives in the family, and in about half of recurrent cases, the same type of anomaly appeared again.17PubMed. Risk of recurrence of craniospinal anomalies These numbers support a multifactorial inheritance model, where many genetic and environmental factors combine to push risk above or below a threshold, rather than a single gene acting as an on/off switch.
A separate study of 35 patients with congenital hydrocephalus and aqueductal stenosis found that a genetic cause with increased sibling recurrence risk could be identified in about 37% of cases. This included not only the well-known X-linked and autosomal recessive forms but also hydrocephalus occurring as part of other inherited syndromes.18PubMed. Congenital hydrocephalus internus and aqueduct stenosis: aetiology and implications for genetic counselling For families receiving genetic counseling, the practical implication is that a thorough diagnostic workup, including genetic testing and detailed imaging, is worth pursuing because it directly affects the recurrence numbers a counselor can offer.
One practical point that sometimes gets overlooked: hydrocephalus may not appear on ultrasound until well into the second half of pregnancy. Screening at 18 weeks alone can miss cases that develop later. Families with a prior history of hydrocephalus or neural tube defects are often advised to have repeat ultrasound scans around 24 weeks to catch late-onset cases.17PubMed. Risk of recurrence of craniospinal anomalies
Environmental and Epigenetic Influences
Even in cases where hydrocephalus has a genetic basis, the environment can modify whether and how severely the condition manifests. Animal research offers some of the clearest illustrations of this. In a rat strain bred to carry inherited hydrocephalus, the baseline rate of the condition was 16 to 20% in first-time mothers. But when mothers were simultaneously nursing a previous litter during the new pregnancy, the rate doubled, and the severity of the hydrocephalus worsened. When the nursing pups were removed, the increase disappeared.19PubMed. The frequency of inherited hydrocephalus is influenced by intrauterine factors in H-Tx rats This demonstrates that the uterine environment, likely through hormonal or nutritional shifts, can dial a genetic predisposition up or down.
In humans, the parallels are harder to prove directly, but the principle holds. Folate supplementation before and during early pregnancy dramatically reduces the risk of neural tube defects, which in turn reduces hydrocephalus associated with spina bifida. Maternal infections during pregnancy, exposure to certain medications, and nutritional deficiencies have all been implicated as environmental modifiers of hydrocephalus risk. The takeaway is that genetics loads the gun, but environment often pulls the trigger, especially for multifactorial forms of the condition.
Gene Therapy and Future Directions
For decades, the primary treatment for hydrocephalus has been surgical: either placing a shunt to divert excess CSF to the abdomen, or creating a new drainage pathway inside the brain through a procedure called endoscopic third ventriculostomy. These approaches manage the fluid problem but do not address the underlying cause, and shunts in particular carry lifelong risks of malfunction and infection. Research into gene therapy for hydrocephalus is still in its early stages, but the concept is straightforward for single-gene forms: if a specific mutation is responsible, delivering a working copy of that gene could, in theory, prevent or reverse the condition.
Prenatal gene therapy is one area of active investigation. The idea is that for conditions like L1CAM-related hydrocephalus, intervening during fetal development, before extensive brain damage occurs, could improve neurodevelopmental outcomes and potentially reduce the need for postnatal surgery.20PubMed. The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review Animal models have been useful for exploring these possibilities; studies in rodents have shown that defects in the junctions between neural stem cells lead to breakdown of the ventricular lining and subsequent hydrocephalus, pointing to specific cellular targets that gene therapy might address.21Exploration of Neuroscience. Innovations in hydrocephalus modeling: bridging animal models, bioengineering platforms, and precision therapies
No human gene therapy trial for hydrocephalus has yet been completed, and significant hurdles remain. The brain is difficult to access with gene-delivery vectors, the timing of intervention would need to be precise, and any prenatal therapy carries risks to both the fetus and the mother. But the expanding use of genetic sequencing means that more families now receive a specific molecular diagnosis, and that diagnosis is a prerequisite for any targeted therapy. Even before gene therapy becomes reality, identifying the genetic cause helps families understand prognosis, connect with other affected families, and make informed decisions about future pregnancies.
Ethical Complexity of Early Genetic Diagnosis
As genetic testing becomes more accessible and is offered earlier in pregnancy, it raises questions that go well beyond the laboratory. When exome sequencing identifies a variant associated with hydrocephalus in a fetus, the clinical picture is not always clear-cut. Some variants have uncertain significance, meaning they look suspicious but have not been definitively linked to disease. Others involve genes with incomplete penetrance, where carrying the mutation does not guarantee the condition will develop or predict how severe it will be.22PubMed Central. The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations
Equity in access is another concern. Advanced genetic testing and fetal MRI are not available everywhere, which means families in well-resourced settings get more precise diagnoses and more options, while families elsewhere may receive a hydrocephalus diagnosis with little information about its cause or prognosis. Incidental findings, where the test reveals a genetic risk unrelated to the original question, add further complexity. These are real dilemmas without easy answers, and they are becoming more common as sequencing technology outpaces the clinical infrastructure needed to interpret and act on the results responsibly.